[HTML][HTML] Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
M Abusalem, L Martiniova, S Soebianto, L DePalatis… - Cancers, 2023 - mdpi.com
Simple Summary The prostate-specific membrane antigen (PSMA) protein present in most
prostate cancer cells has emerged as a promising target for the imaging and treatment of …
prostate cancer cells has emerged as a promising target for the imaging and treatment of …
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
M Abusalem, L Martiniova, S Soebianto… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is one of the most prevalent cancer diagnoses among men in the
United States and in several other developed countries. The prostate specific membrane …
United States and in several other developed countries. The prostate specific membrane …
[HTML][HTML] Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
M Abusalem, L Martiniova, S Soebianto, L DePalatis… - Cancers, 2023 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is one of the most prevalent cancer diagnoses among men in the
United States and in several other developed countries. The prostate specific membrane …
United States and in several other developed countries. The prostate specific membrane …
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
M Abusalem, L Martiniova, S Soebianto, L DePalatis… - Cancers, 2023 - europepmc.org
Prostate cancer (PCa) is one of the most prevalent cancer diagnoses among men in the
United States and in several other developed countries. The prostate specific membrane …
United States and in several other developed countries. The prostate specific membrane …
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy.
M Abusalem, L Martiniova, S Soebianto… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: The prostate-specific membrane antigen (PSMA) protein present
in most prostate cancer cells has emerged as a promising target for the imaging and …
in most prostate cancer cells has emerged as a promising target for the imaging and …
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy.
M Abusalem, L Martiniova, S Soebianto, L DePalatis… - Cancers, 2023 - go.gale.com
The prostate-specific membrane antigen (PSMA) protein present in most prostate cancer
cells has emerged as a promising target for the imaging and treatment of prostate cancer …
cells has emerged as a promising target for the imaging and treatment of prostate cancer …
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
M Abusalem, L Martiniova, S Soebianto, L DePalatis… - …, 2023 - search.proquest.com
Prostate cancer (PCa) is one of the most prevalent cancer diagnoses among men in the
United States and in several other developed countries. The prostate specific membrane …
United States and in several other developed countries. The prostate specific membrane …
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
M Abusalem, L Martiniova, S Soebianto… - …, 2023 - mdanderson.elsevierpure.com
Prostate cancer (PCa) is one of the most prevalent cancer diagnoses among men in the
United States and in several other developed countries. The prostate specific membrane …
United States and in several other developed countries. The prostate specific membrane …
Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy.
M Abusalem, L Martiniova, S Soebianto, L DePalatis… - Cancers, 2023 - europepmc.org
Prostate cancer (PCa) is one of the most prevalent cancer diagnoses among men in the
United States and in several other developed countries. The prostate specific membrane …
United States and in several other developed countries. The prostate specific membrane …